bpc-157 adverse effects humans case reports Is BPC‑157 a Risk? Safety, Side Effects, and Concerns Explained This doesn't mean BPC-157 is
Description
We invoice in EUR
Semax Developed in Soviet-era Russian neuropeptide research
No Impact on IGF-1 or Blood Sugar Levels Unlike full growth hormone therapy, which can increase IGF-1 and affect glucose metabolism, AOD-9604: Does not elevate IGF-1 levels, reducing the risk of unwanted anabolic effects or organ enlargement
As of April 2026, no FDA guidance formally distinguishing PDA from BPC-157 has been issued
